A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.
暂无分享,去创建一个
L. Rimassa | T. Pressiani | V. Lorusso | S. Siena | C. Carnaghi | C. Oliva | M. Ronzoni | A. Comandone | E. Mari | M. Zuradelli | C. Granetti | A. Santoro